Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 708

1.

Investigation of the mechanisms by which hot isostatic pressing improves the fatigue performance of powder bed fused Ti-6Al-4V.

Li P, Warner DH, Pegues JW, Roach MD, Shamsaei N, Phan N.

Int J Fatigue. 2019 Mar;120:342-352. doi: 10.1016/j.ijfatigue.2018.10.015. Epub 2018 Oct 29.

PMID:
31595096
2.

Long-Term Outcomes with 3-Dimensional Conformal External Beam Accelerated Partial Breast Irradiation.

Kennedy WR, Roach MC, Thomas MA, Ochoa L, Altman MB, Hernandez-Aya LF, Cyr AE, Margenthaler JA, Zoberi I.

Pract Radiat Oncol. 2019 Sep 18. pii: S1879-8500(19)30271-1. doi: 10.1016/j.prro.2019.09.007. [Epub ahead of print]

PMID:
31541717
3.

Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: FDA Oncology Center of Excellence Public Workshop.

Weinstock C, Suzman D, Kluetz P, Baxley J, Viviano C, Ibrahim A, Jarow J, Sridhara R, Liu K, Carroll P, Eggener S, Hu JC, Hussain M, King M, Klein E, Kungel T, Makarov D, Pinto PA, Rini B, Roach M, Sandler H, Schlegel PN, Song D, Goldberg K, Pazdur R, Beaver JA.

J Urol. 2019 Sep 10:101097JU0000000000000532. doi: 10.1097/JU.0000000000000532. [Epub ahead of print]

PMID:
31502940
4.

Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRT.

Kennedy WR, Gabani P, Nikitas J, Robinson CG, Bradley JD, Roach MC.

Radiother Oncol. 2019 Aug 31. pii: S0167-8140(19)33056-7. doi: 10.1016/j.radonc.2019.08.010. [Epub ahead of print]

PMID:
31481272
5.

Demonstration of Pressure Reduction in a New Proof of Concept Spine Board.

Sun H, Wilson J, Roach MJ, Hefzy MS, Nemunaitis G.

Assist Technol. 2019 Aug 22. doi: 10.1080/10400435.2019.1658658. [Epub ahead of print] No abstract available.

PMID:
31437094
6.

Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer.

Xu MJ, Kornberg Z, Gadzinski AJ, Diao D, Cowan JE, Wu SY, Boreta L, Spratt DE, Behr SC, Nguyen HG, Cooperberg MR, Davicioni E, Roach M 3rd, Hope TA, Carroll PR, Feng FY.

Eur Urol Oncol. 2019 Jan 14. pii: S2588-9311(18)30194-9. doi: 10.1016/j.euo.2018.11.002. [Epub ahead of print]

PMID:
31411984
7.

Why foreign STEM PhDs are unlikely to work for US technology startups.

Roach M, Skrentny J.

Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):16805-16810. doi: 10.1073/pnas.1820079116. Epub 2019 Aug 5.

8.

A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer.

Ventimiglia E, Seisen T, Abdollah F, Briganti A, Fonteyne V, James N, Roach M 3rd, Thalmann GN, Touijer K, Chen RC, Cheng L.

Eur Urol Oncol. 2019 May;2(3):294-301. doi: 10.1016/j.euo.2019.02.001. Epub 2019 Mar 23. Review.

PMID:
31200844
9.

Osteoblast response to nanostructured and phosphorus-enhanced titanium anodization surfaces.

Jain S, Williamson RS, Janorkar AV, Griggs JA, Roach MD.

J Biomater Appl. 2019 Sep;34(3):419-430. doi: 10.1177/0885328219852741. Epub 2019 May 24. No abstract available.

PMID:
31126206
10.

Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.

Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson WJ, Kane CJ, Terris MK, Zumsteg ZS, Butler S, Osborne JR, Morgan TM, Mehra R, Salami SS, Kishan AU, Wang C, Schaeffer EM, Roach M 3rd, Pisansky TM, Shipley WU, Freedland SJ, Sandler HM, Halabi S, Feng FY, Dignam JJ, Nguyen PL, Schipper MJ, Spratt DE.

JAMA Oncol. 2019 Jul 1;5(7):975-983. doi: 10.1001/jamaoncol.2019.0826.

11.

Optimizing Imperfect Patient Management Recommendations Post-prostatectomy.

Roach M 3rd, Lazar AA.

Eur Urol Oncol. 2018 May;1(1):19-20. doi: 10.1016/j.euo.2018.03.014. Epub 2018 May 15. No abstract available.

PMID:
31100223
12.

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Mohler JL, Antonarakis ES, Armstrong AJ, D'Amico AV, Davis BJ, Dorff T, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Ippolito JE, Kane CJ, Kuettel MR, Lang JM, McKenney J, Netto G, Penson DF, Plimack ER, Pow-Sang JM, Pugh TJ, Richey S, Roach M, Rosenfeld S, Schaeffer E, Shabsigh A, Small EJ, Spratt DE, Srinivas S, Tward J, Shead DA, Freedman-Cass DA.

J Natl Compr Canc Netw. 2019 May 1;17(5):479-505. doi: 10.6004/jnccn.2019.0023.

PMID:
31085757
13.

Surgical and Nonsurgical Treatment of Penetrating Spinal Cord Injury: Analysis of Long-term Neurological and Functional Outcomes.

Kelly ML, Roach MJ, Nemunaitis G, Chen Y.

Top Spinal Cord Inj Rehabil. 2019 Spring;25(2):186-193. doi: 10.1310/sci2502-186.

PMID:
31068749
14.

Stampede to Cure.

Li YR, Roach M 3rd.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):264. doi: 10.1016/j.ijrobp.2018.09.046. No abstract available.

PMID:
31047624
15.

Anatomical Adaptation-Early Clinical Evidence of Benefit and Future Needs in Lung Cancer.

Kavanaugh J, Hugo G, Robinson CG, Roach MC.

Semin Radiat Oncol. 2019 Jul;29(3):274-283. doi: 10.1016/j.semradonc.2019.02.009. Review.

PMID:
31027644
16.

Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials.

Hallemeier CL, Zhang P, Pisansky TM, Hanks GE, McGowan DG, Roach M 3rd, Zeitzer KL, Firat SY, Husain SM, D'Souza DP, Souhami L, Parliament MB, Rosenthal SA, Lukka HR, Rotman M, Horwitz EM, Miles EF, Paulus R, Sandler HM.

Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1057-1065. doi: 10.1016/j.ijrobp.2019.03.049. Epub 2019 Apr 6.

PMID:
30959123
17.

Brief Report: Hazardous Cannabis Use and Monocyte Activation Among Methamphetamine Users With Treated HIV Infection.

Vidot DC, Manuzak JA, Klatt NR, Pallikkuth S, Roach M, Dilworth SE, Pahwa S, Carrico AW.

J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):361-364. doi: 10.1097/QAI.0000000000002046.

PMID:
30958388
18.

Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer.

Rudra S, Jiang N, Rosenberg SA, Olsen JR, Roach MC, Wan L, Portelance L, Mellon EA, Bruynzeel A, Lagerwaard F, Bassetti MF, Parikh PJ, Lee PP.

Cancer Med. 2019 May;8(5):2123-2132. doi: 10.1002/cam4.2100. Epub 2019 Apr 1.

19.

Treatment response as predictor for brain metastasis in triple negative breast cancer: A score-based model.

Gabani P, Weiner AA, Hernandez-Aya LF, Khwaja S, Roach MC, Ochoa LL, Mullen D, Thomas MA, Matesa MA, Margenthaler JA, Cyr AE, Naughton MJ, Ma C, Sanati S, Zoberi I.

Breast J. 2019 May;25(3):363-372. doi: 10.1111/tbj.13230. Epub 2019 Mar 28.

PMID:
30920124
20.

Treatment of T3N0 non-small cell lung cancer with chest wall invasion using stereotactic body radiotherapy.

Kennedy WR, Gabani P, Nikitas J, Samson PP, Robinson CG, Bradley JD, Roach MC.

Clin Transl Radiat Oncol. 2019 Feb 21;16:1-6. doi: 10.1016/j.ctro.2019.02.004. eCollection 2019 May.

21.

Combining stereotactic body radiation therapy with immunotherapy: current data and future directions.

Lin AJ, Roach M, Bradley J, Robinson C.

Transl Lung Cancer Res. 2019 Feb;8(1):107-115. doi: 10.21037/tlcr.2018.08.16. Review.

22.

Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial.

Henke LE, Olsen JR, Contreras JA, Curcuru A, DeWees TA, Green OL, Michalski J, Mutic S, Roach MC, Bradley JD, Parikh PJ, Kashani R, Robinson CG.

Adv Radiat Oncol. 2018 Oct 18;4(1):201-209. doi: 10.1016/j.adro.2018.10.003. eCollection 2019 Jan-Mar.

23.

Differences in United States Insurance Payer Policies and American Society for Radiation Oncology's (ASTRO) Model Policy on Stereotactic Body Radiation Therapy (SBRT).

Roach MC, Thomas TO, Paravati AJ, Mahajan A.

Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):740-744. doi: 10.1016/j.ijrobp.2019.01.005. Epub 2019 Jan 21.

PMID:
30677470
24.

Inactivating Mutations in Irc7p Are Common in Wine Yeasts, Attenuating Carbon-Sulfur β-Lyase Activity and Volatile Sulfur Compound Production.

Cordente AG, Borneman AR, Bartel C, Capone D, Solomon M, Roach M, Curtin CD.

Appl Environ Microbiol. 2019 Mar 6;85(6). pii: e02684-18. doi: 10.1128/AEM.02684-18. Print 2019 Mar 15.

25.

Surgery Versus Radiation for High-risk Prostate Cancer: The Fight Continues. But Is It Time To Call a Draw and Reach Consensus?

Sooriakumaran P, Pavan N, Wiklund PN, Roach M 3rd.

Eur Urol. 2019 Apr;75(4):556-557. doi: 10.1016/j.eururo.2018.12.032. Epub 2019 Jan 11. No abstract available.

PMID:
30639140
26.

Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer.

Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M 3rd, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA.

Urology. 2019 Mar;125:154-162. doi: 10.1016/j.urology.2018.09.038. Epub 2018 Dec 21.

PMID:
30580002
27.

Brettanomyces bruxellensis SSU1 Haplotypes Confer Different Levels of Sulfite Tolerance When Expressed in a Saccharomyces cerevisiae SSU1 Null Mutant.

Varela C, Bartel C, Roach M, Borneman A, Curtin C.

Appl Environ Microbiol. 2019 Feb 6;85(4). pii: e02429-18. doi: 10.1128/AEM.02429-18. Print 2019 Feb 15.

28.

Purge Haplotigs: allelic contig reassignment for third-gen diploid genome assemblies.

Roach MJ, Schmidt SA, Borneman AR.

BMC Bioinformatics. 2018 Nov 29;19(1):460. doi: 10.1186/s12859-018-2485-7.

29.

Stereotactic Body Radiotherapy for Early-Stage Multiple Primary Lung Cancers.

Nikitas J, DeWees T, Rehman S, Abraham C, Bradley J, Robinson C, Roach M.

Clin Lung Cancer. 2019 Mar;20(2):107-116. doi: 10.1016/j.cllc.2018.10.010. Epub 2018 Nov 3.

PMID:
30477740
30.

Population sequencing reveals clonal diversity and ancestral inbreeding in the grapevine cultivar Chardonnay.

Roach MJ, Johnson DL, Bohlmann J, van Vuuren HJJ, Jones SJM, Pretorius IS, Schmidt SA, Borneman AR.

PLoS Genet. 2018 Nov 20;14(11):e1007807. doi: 10.1371/journal.pgen.1007807. eCollection 2018 Nov.

31.

Getting pre-exposure prophylaxis to high-risk transgender women: lessons from Detroit, USA.

Hood JE, Eljallad T, Abad J, Connolly M, Heumann C, Fritz J, Roach M, Lukomski D, Golden MR.

Sex Health. 2018 Nov;15(6):562-569. doi: 10.1071/SH18063.

PMID:
30384881
32.

Regionalization of Spine Trauma Care in an Urban Trauma System in the United States: Decreased Time to Surgery and Hospital Length of Stay.

Kelly ML, He J, Roach MJ, Moore TA, Steinmetz MP, Claridge JA.

Neurosurgery. 2018 Oct 16. doi: 10.1093/neuros/nyy452. [Epub ahead of print]

PMID:
30329091
33.

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.

Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM.

Lancet Oncol. 2018 Nov;19(11):1504-1515. doi: 10.1016/S1470-2045(18)30528-X. Epub 2018 Oct 10. Erratum in: Lancet Oncol. 2018 Nov;19(11):e581.

PMID:
30316827
34.

A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526).

Crook JM, Zhang P, Pisansky TM, Trabulsi EJ, Amin MB, Bice W, Morton G, Pervez N, Vigneault E, Catton C, Michalski J, Roach M 3rd, Beyer D, Jani A, Horwitz E, Donavanik V, Sandler H.

Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):335-343. doi: 10.1016/j.ijrobp.2018.09.039. Epub 2018 Oct 9.

PMID:
30312717
35.

Clinical trials involving carbon-ion radiation therapy and the path forward.

Lazar AA, Schulte R, Faddegon B, Blakely EA, Roach M 3rd.

Cancer. 2018 Dec 1;124(23):4467-4476. doi: 10.1002/cncr.31662. Epub 2018 Oct 11. Review.

PMID:
30307603
36.

A novel MRI segmentation method using CNN-based correction network for MRI-guided adaptive radiotherapy.

Fu Y, Mazur TR, Wu X, Liu S, Chang X, Lu Y, Li HH, Kim H, Roach MC, Henke L, Yang D.

Med Phys. 2018 Nov;45(11):5129-5137. doi: 10.1002/mp.13221. Epub 2018 Oct 28.

PMID:
30269345
37.

Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy.

DeWees TA, Nikitas J, Rehman S, Bradley JD, Robinson CG, Roach MC.

Pract Radiat Oncol. 2019 Jan;9(1):e83-e89. doi: 10.1016/j.prro.2018.09.001. Epub 2018 Sep 20.

PMID:
30244094
38.

Combining immunotherapy with radiation therapy in thoracic oncology.

Badiyan SN, Roach MC, Chuong MD, Rice SR, Onyeuku NE, Remick J, Chilukuri S, Glass E, Mohindra P, Simone CB 2nd.

J Thorac Dis. 2018 Aug;10(Suppl 21):S2492-S2507. doi: 10.21037/jtd.2018.05.73. Review.

39.

Optimizing radiation dose and fractionation for the definitive treatment of locally advanced non-small cell lung cancer.

Roach MC, Bradley JD, Robinson CG.

J Thorac Dis. 2018 Aug;10(Suppl 21):S2465-S2473. doi: 10.21037/jtd.2018.01.153. Review.

40.

Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities.

Xiao C, Moughan J, Movsas B, Konski AA, Hanks GE, Cox JD, Roach M 3rd, Zeitzer KL, Lawton CA, Peters CA, Rosenthal SA, Hsu IJ, Horwitz EM, Mishra MV, Michalski JM, Parliament MB, D'Souza DP, Pugh SL, Bruner DW.

Adv Radiat Oncol. 2018 Jun 7;3(3):405-411. doi: 10.1016/j.adro.2018.04.010. eCollection 2018 Jul-Sep.

41.

Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A 4.5-Year Clinical Experience.

Henke LE, Contreras JA, Green OL, Cai B, Kim H, Roach MC, Olsen JR, Fischer-Valuck B, Mullen DF, Kashani R, Thomas MA, Huang J, Zoberi I, Yang D, Rodriguez V, Bradley JD, Robinson CG, Parikh P, Mutic S, Michalski J.

Clin Oncol (R Coll Radiol). 2018 Nov;30(11):720-727. doi: 10.1016/j.clon.2018.08.010. Epub 2018 Sep 7.

PMID:
30197095
42.

Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital-based analysis of patterns of care, RT fractionation scheme, and overall survival.

Fischer-Valuck BW, Baumann BC, Apicelli A, Rao YJ, Roach M, Daly M, Dans MC, White P, Contreras J, Henke L, Gay H, Michalski JM, Abraham C.

Cancer Med. 2018 Sep;7(9):4240-4250. doi: 10.1002/cam4.1655. Epub 2018 Aug 17.

43.

Clínica Comunitaria Esperanza: Strategy for Health Promotion and Engagement With Hispanic Communities.

Davids AH, Sommese KJ, Roach MV, Lee SJ, Crose CE, Khan SB, Leader AP.

Health Promot Pract. 2018 Aug 13:1524839918784942. doi: 10.1177/1524839918784942. [Epub ahead of print]

PMID:
30103623
44.

Microbial Translocation and Immune Activation in HIV-1 Infected Pregnant Women.

Mitchell CD, Dominguez S, Roach M, George V, Rinaldi S, Fischl M, Potter J, Tyson B, Pahwa S.

Curr HIV Res. 2018;16(3):208-215. doi: 10.2174/1570162X16666180731145011.

PMID:
30062968
45.

Stereotactic Body Radiation Therapy for Central Early-Stage NSCLC: Results of a Prospective Phase I/II Trial.

Roach MC, Robinson CG, DeWees TA, Ganachaud J, Przybysz D, Drzymala R, Rehman S, Kashani R, Bradley JD.

J Thorac Oncol. 2018 Nov;13(11):1727-1732. doi: 10.1016/j.jtho.2018.07.017. Epub 2018 Jul 26.

PMID:
30056162
46.

Craniectomy and Craniotomy in Traumatic Brain Injury: A Propensity-Matched Analysis of Long-Term Functional and Quality of Life Outcomes.

Kelly ML, Shammassian B, Roach MJ, Thomas C, Wagner AK.

World Neurosurg. 2018 Oct;118:e974-e981. doi: 10.1016/j.wneu.2018.07.124. Epub 2018 Jul 24.

PMID:
30048790
47.

Psychosocial Correlates of Monocyte Activation and HIV Persistence in Methamphetamine Users.

Grosgebauer K, Salinas J, Sharkey M, Roach M, Pallikkuth S, Dilworth SE, Pahwa S, Koru-Sengul T, Stevenson M, Carrico AW.

J Neuroimmune Pharmacol. 2019 Mar;14(1):16-22. doi: 10.1007/s11481-018-9797-2. Epub 2018 Jul 25.

PMID:
30046962
48.

Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy.

Chapman CH, Braunstein SE, Pouliot J, Noworolski SM, Weinberg V, Cunha A, Kurhanewicz J, Gottschalk AR, Roach MI, Hsu IC.

J Contemp Brachytherapy. 2018 Jun;10(3):193-201. doi: 10.5114/jcb.2018.76881. Epub 2018 Jun 29.

49.

Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.

Lukka HR, Pugh SL, Bruner DW, Bahary JP, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, Roach M 3rd, Pinover WH, Beyer DC, Amanie JO, Sandler HM, Kachnic LA.

Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):287-295. doi: 10.1016/j.ijrobp.2018.06.008. Epub 2018 Jun 18.

50.

Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule.

Samson P, Rehman S, Juloori A, DeWees T, Roach M, Bradley J, Videtic GMM, Stephans K, Robinson C.

Pract Radiat Oncol. 2018 Nov - Dec;8(6):404-413. doi: 10.1016/j.prro.2018.04.004. Epub 2018 Apr 10.

PMID:
29907514

Supplemental Content

Support Center